NCT05916105

Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting

Drug Utilization Evaluation Study of Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting: A Cross-Sectional Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 151 (actual)
• Sponsor: Damanhour University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: —

Summary

Background: Ciprofloxacin is a fluoroquinolone that is commonly used to treat a variety of diseases. Ciprofloxacin resistance is rising, resulting in suboptimal patient care. The goal of this study was to evaluate ciprofloxacin use in the community in terms of acceptable prescription, dose, frequency, and duration of use. Methods: A cross-sectional research was done in Egyptian community pharmacies by community pharmacists. Patients who were administered oral ciprofloxacin during the research period were included.

Detailed description

From September 2021 to February 2022, a cross-sectional, research was undertaken to evaluate ciprofloxacin usage. The investigation was carried out by community pharmacists in seven Egyptian community pharmacies. Data Collection: data gathered from pharmacy patients' records on a data collection form that included the factors indicated. The General Symptoms Questionnaire, physical examination, and blood testing were used to identify adverse occurrences. Study variables: * age, gender, pregnancy/lactation * Department/indication * Dose, Frequency, Duration, Adverse events, Drug interactions. Data was categorized and analyzed using appropriate software.

Conditions

• Ciprofloxacin Adverse Reaction

Interventions

Type	Name	Description
DRUG	Ciprofloxacin Tablets	Ciprofloxacin antibiotic

Timeline

• Start date: 2021-09-01
• Primary completion: 2022-02-28
• Completion: 2022-03-01
• First posted: 2023-06-23
• Last updated: 2023-06-23

Locations

1 site across 1 country: Egypt